Nexalin Technology, Inc. (NXL): Entry into a Material Definitive Agreement
Nexalin Technology, Inc. (NXL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 6 nexalintec_ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE SUCH TERMS ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THESE REDACTED TERMS HAVE BEEN MARKED IN THIS EXHIBIT WITH
How this was made
The 30-second read
Why it matters
The cash infusion may extend runway, but share issuance could dilute existing shareholders.
Market read
Primary disclosure of a modest private placement; limited immediate trading impact but worth monitoring for dilution risk.
What to watch
Terms of the agreement (pricing, warrants) are redacted; actual dilution could be higher if warrants are exercised.
Background
The 8‑K filing discloses a private placement under Regulation D, a common financing route for micro‑caps.
Ticker impact
Nexalin Technology filed an 8‑K reporting a Material Definitive Agreement to sell up to $15 million of common shares to Alumni Capital LP.
Modest downward pressure as shares may be issued, but cash could support near‑term stability.
The agreement is a primary disclosure of a private placement; size is modest for a micro‑cap, so impact is limited.
Market effects
May signal increased financing activity in the biotech/tech micro‑cap sector.
Limited to U.S. OTC markets where NXL trades.
Low; no broader macro or sector shock.
Counterpoint
If the capital raise is used for value‑creating R&D, the dilution could be outweighed by future upside.
Key entities
- companyNexalin Technology, Inc.
Issuer of the securities.
- investorAlumni Capital LP
Purchaser of up to $15M of common shares.
